Evidence map›Paper›PMID 35420712›Full record

ReviewChemPlusChem2022

Enzymatic Noncovalent Synthesis for Targeting Subcellular Organelles.

Qiuxin Zhang, Weiyi Tan, Bing Xu

Abstract readReview
In one paragraph

Review in ChemPlusChem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. AnChemical science · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qiuxin ZhangDepartment of Chemistry, Brandeis University, 415 South Street, Waltham, MA 02454, USA.ORCID http://orcid.org/0000-0002-8659-3569
Weiyi TanDepartment of Chemistry, Brandeis University, 415 South Street, Waltham, MA 02454, USA.
Bing XuDepartment of Chemistry, Brandeis University, 415 South Street, Waltham, MA 02454, USA.ORCID http://orcid.org/0000-0002-4639-387X

Funding

Subcellular Enzyme-instructed self-assembly for molecular anticancer nanomedicinesR01CA142746 · NCI · BRANDEIS UNIVERSITY · PI Bing Xu · 2010 to 2026
$6.4M
Exploring enzyme-instructed self-assembly (EISA) for targeting osteoblastic metastasis of prostate cancerR21CA252364 · NCI · BRANDEIS UNIVERSITY · PI HSIEH, JER-TSONG, XU, BING · 2020 to 2020
$430k
NCI NIH HHS R01 CA142746NCI NIH HHS R21 CA252364NIH HHS CA142746NIH HHS CA252364
6 · The paper itself

Abstract

Enzymatic noncovalent synthesis (ENS) exploits enzymatic reactions to produce spatially organized higher-order supramolecular assemblies that modulate cellular processes. While ENS is a general mechanism to create higher-order assemblies of proteins for diverse cellular functions, the exploration of ENS of other bioactive molecules, such as peptides or small organic molecules, is rather limited. Since ENS generates non-diffusive supramolecular assemblies locally, it provides a unique approach to targeting subcellular organelles. In this Review, we highlight the recent progress of the application of ENS of peptide assemblies for targeting subcellular organelles. After a brief introduction of the concept of ENS, we introduce the case of generating artificial filaments by ENS in cell cytosol, then discuss the use of ENS for targeting endoplasmic reticulum, mitochondria, Golgi apparatus, and lysosomes, and finally we describe the targeting of nucleus by ENS. We hope to illustrate the promise of ENS, as a localized molecular process in an open system, for understanding diseases, controlling cell behaviors, and developing new therapeutics.

Indexed as

enzymesorganellespeptidesself-assemblysupramolecular chemistry

Identifiers

PMID35420712
PMCPMC9508291

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.